Medical Modeling, a healthcare products manufacturer based in Golden, Colorado, announced that the United States Food and Drug Administration (FDA) approved its Virtual Surgical Planning system. The technology has been fully-commercialized in both Canada and the United States.

According to a press release by the company, the Virtual Surgical Planning system gives healthcare providers the ability to plan maxillofacial surgical operations in a simulated virtual reality environment. Once an approach for surgery has been planned in the virtual system, physicians can implement that approach with a patient.

Andy Christensen is president of Medical Modeling. In prepared remarks, he said, "The entire team at Medical Modeling could not be more pleased with the FDA's clearance of our VSP System product line. It's exciting to see personalized technology such as this that benefits the surgeon and the patient really catching hold."

Potential applications for the technology include orthognathic reconstruction and surgery. In addition, the surgical planning technology can be employed in a variety of different procedures.

VSP Orthognathics employs both computer-aided design (CAD) surgical splints and planning for orthognathic surgery. VSP Reconstruction gives healthcare providers the ability to apply planning to the surgical reconstruction of the maxilla or the mandible through the use of vascularized grafts taken from parts of a patient’s body.

References

http://www.medicalmodeling.com/flashsite/splash.html

www.prnewswire.com/news-releases/medical-modeling-receives-fda-510k-clea...